Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Ferrara

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Mabs|June 25, 2025
Developing drug-like single-domain antibodies (VHH) from in vitro librariesM Frank Erasmus, Andre A R Teixeira, Esteban Molina, et al.
Scientific Reports|February 7, 2024
Author Correction: Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Mabs|August 28, 2024
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developabilityFortunato Ferrara, Adeline Fanni, Andre A R Teixeira, et al.
Scientific Reports|December 19, 2023
Author Correction: Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Scientific Reports|October 26, 2023
Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Elife|August 14, 2024
Antibody characterization is critical to enhance reproducibility in biomedical researchRichard A Kahn, Harvinder Virk, Carl Laflamme, et al.
Blood Advances|January 22, 2026
HMB-002: A Monovalent Antibody that Elevates Circulating VWF and FVIII Levels for Treatment of Von Willebrand DiseaseMattias Häger, Minka Zivkovic, Prafull S Gandhi, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2016
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo releaseHitomi Hosoya, Andrey S Dobroff, Wouter H P Driessen, et al.
Mabs|February 28, 2018
When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regionsAndrew R M Bradbury, Nathan D Trinklein, Holger Thie, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Mabs|June 25, 2025
Developing drug-like single-domain antibodies (VHH) from in vitro librariesM Frank Erasmus, Andre A R Teixeira, Esteban Molina, et al.
Scientific Reports|February 7, 2024
Author Correction: Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Mabs|August 28, 2024
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developabilityFortunato Ferrara, Adeline Fanni, Andre A R Teixeira, et al.
Scientific Reports|December 19, 2023
Author Correction: Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Scientific Reports|October 26, 2023
Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Elife|August 14, 2024
Antibody characterization is critical to enhance reproducibility in biomedical researchRichard A Kahn, Harvinder Virk, Carl Laflamme, et al.
Blood Advances|January 22, 2026
HMB-002: A Monovalent Antibody that Elevates Circulating VWF and FVIII Levels for Treatment of Von Willebrand DiseaseMattias Häger, Minka Zivkovic, Prafull S Gandhi, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2016
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo releaseHitomi Hosoya, Andrey S Dobroff, Wouter H P Driessen, et al.
Mabs|February 28, 2018
When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regionsAndrew R M Bradbury, Nathan D Trinklein, Holger Thie, et al.
Pageof 6